Search Results for: California Stem Cell Treatment Center

Testimony in supermodel stem cell fraud case: “I lied to patients”

/ / 6 Comments

“I lied to patients,” testified a weeping, young woman in court related to a fraud allegation involving stem cells. She had worked as an office assistant at a company that injected bogus and potentially dangerous cow-based “stem cell” treatments into human patients. This company, which in different incarnations went by various names including Biomark in […]

Testimony in supermodel stem cell fraud case: “I lied to patients” Read More »

From boobs to baldness 2.0: Cosmetic stem cell clinics proliferate

/ / 6 Comments
som_stoty_b1

A month ago I did a very widely read piece on cosmetic applications of stem cell technologies in the U.S. called “from boobs to baldness”. Many cosmetics websites asked for permission to run the piece and it was re-run in a number of languages around the world as well. It is clear there is big

From boobs to baldness 2.0: Cosmetic stem cell clinics proliferate Read More »

Stem cell predictions for 2012: Science, CIRM, ACT, trends

/ / 4 Comments
stem-cell-predictions

Each year at this time I start thinking about what the next year will bring for the stem cell field and make predictions. This year is no different and I’ve been pondering what 2012 has in store for us.  You can read my predictions for 2011 here and see how I fared. Not too bad, but overly optimistic

Stem cell predictions for 2012: Science, CIRM, ACT, trends Read More »

Why did clinic supplier Liveyon halt sales but others kept going despite FDA?

/ / 1 Comment
Liveyon-reincarnated

Umbilical “stem cell” supplier Liveyon has suspended sales of its products according to the WaPo after a harsh FDA warning letter. While not fully shutting off the tap to the perinatal stem cell clinic universe, as other suppliers including in Utah seem to be continuing, this Liveyon voluntary hold will equal a major reduction in

Why did clinic supplier Liveyon halt sales but others kept going despite FDA? Read More »

US clinics widely selling unproven RNA therapy, supportive oligonucleotide therapy or SOT, from Greek firm RGCC

/ / 8 Comments
SOT, supportive oligonucleotide therapy

A few dozen clinics in the US sell an unproven RNA therapy called supportive oligonucleotide therapy or SOT. The product comes from a Greek firm RGCC or Research Genetic Cancer Center, which also pre-tests patients’ gene expression to design the RNA product. Clinics marketing SOT in the US say it is intended to act by

US clinics widely selling unproven RNA therapy, supportive oligonucleotide therapy or SOT, from Greek firm RGCC Read More »

Weekly reads: Xist & autoimmune disease in women, Crohn’s disease, dumb headline of the week

/ / Leave a Comment
Xist ,auto immune disease

Readers of The Niche have asked me many questions about stem cells for autoimmune disease but the puzzle of why women get these conditions more often than men hasn’t come up before here. For instance, why is MS so much more common in women than men? It’s remained somewhat of a mystery over the years.

Weekly reads: Xist & autoimmune disease in women, Crohn’s disease, dumb headline of the week Read More »

Weekly reads: clonal expansion, Golden Retriever cancer, FTC hits genetics firm on testi-phony-als

/ / 1 Comment
clonal selection

Let’s start this week’s digest with a discussion of clonal expansion and mutations during cell and gene therapy development. Here’s the article that brought this to mind. Sickle cell gene therapy process may cause cancer-linked mutations in blood stem cells, Fierce Biotech. Clonal expansion This is a story about a non-CRISPR gene therapy using a

Weekly reads: clonal expansion, Golden Retriever cancer, FTC hits genetics firm on testi-phony-als Read More »

Burst Biologics unapproved biologic used by Weill Cornell: was there a cover-up?

/ / 3 Comments
Burst Biologics, Christopher Jones

The New York Times just broke a story on Burst Biologics and Weill Cornell that fits with long-standing troubling questions about regenerative biologics producers. The story also bears on the doctors and hospitals like Weill Cornell that were or are customers of the suppliers. Further, what is the FDA’s role in all of this? The

Burst Biologics unapproved biologic used by Weill Cornell: was there a cover-up? Read More »